Nutra Pharma Corp SEC filings NPHC

Nutra Pharma Corp has 349 filings in SEC EDGAR's recent list, going back to Aug 24, 2000. Its latest annual report, Form 10-K, was filed on May 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 2, 2026 (change in control). The company's fiscal year ends on December 31.

Nutra Pharma Corp SEC filings
Form Description Filed Period
NT 10-Q Filing Aug 14, 2026 Jun 30, 2026
NT 10-Q Filing Nov 15, 2022 Sep 30, 2022
NT 10-Q Filing Aug 15, 2022 Jun 30, 2022
NT 10-Q Filing May 16, 2022 Mar 31, 2022
NT 10-K Filing Apr 1, 2022 Dec 31, 2021
NT 10-K Filing Apr 1, 2019 Dec 31, 2018
NT 10-Q Form nt 10-q Nov 14, 2018 Sep 30, 2018
NT 10-Q Form nt 10-q Aug 14, 2018 Jun 30, 2018
NT 10-Q Form nt 10-q May 15, 2018 Mar 31, 2018
NT 10-K Filing Apr 2, 2018 Dec 31, 2017
NT 10-Q Form nt 10-q Nov 14, 2017 Sep 30, 2017
NT 10-Q Form nt 10-q May 15, 2017 Mar 31, 2017
NT 10-K Filing Mar 31, 2017 Dec 31, 2016
NT 10-Q Form nt 10-q Nov 15, 2016 Sep 30, 2016
NT 10-Q Form nt 10-q Aug 15, 2016 Jun 30, 2016
NT 10-Q Form nt 10-q May 17, 2016 Mar 31, 2016
NT 10-K Filing Mar 30, 2016 Dec 31, 2015
NT 10-Q Filing Nov 17, 2015 Sep 30, 2015
NT 10-Q Filing Aug 17, 2015 Jun 30, 2015
NT 10-Q Filing May 18, 2015 Mar 31, 2015
NT 10-K Filing Apr 1, 2015 Dec 31, 2014
NT 10-Q Filing May 16, 2014 Mar 31, 2014
NTN 10Q Notification of late filing Nov 18, 2013 Sep 30, 2013
NT 10-Q Form 12b-25 Aug 15, 2013 Jun 30, 2013
NT 10-Q Form 12b-25 May 15, 2013 Mar 31, 2013
NT 10-K Filing Apr 1, 2013 Dec 31, 2012
NT 10-K Filing Apr 2, 2012 Dec 31, 2011
NT 10-Q Notification of late filing for form 10-q Nov 15, 2011 Sep 30, 2011
NT 10-K Filing Apr 1, 2011 Dec 31, 2010
EFFECT Filing Jan 7, 2011 —
UPLOAD Letter from the SEC Jun 24, 2010 —
NT 10-Q Filing May 18, 2010 Mar 31, 2010
CORRESP Letter to the SEC Apr 8, 2010 —
NT 10-K Filing Apr 1, 2010 Dec 31, 2009
UPLOAD Letter from the SEC Mar 22, 2010 —
CORRESP Letter to the SEC Jan 25, 2010 —
CORRESP Letter to the SEC Jan 13, 2010 —
CORRESP Letter to the SEC Dec 16, 2009 —
UPLOAD Letter from the SEC Dec 15, 2009 —
NT 10-Q Filing Nov 17, 2009 Sep 30, 2009
NT 10-Q Filing Aug 17, 2009 Jun 30, 2009
NT 10-Q Filing May 15, 2009 Mar 31, 2009
NT 10-K Filing Apr 1, 2009 Dec 31, 2008
NT 10-Q Filing Nov 17, 2008 Sep 30, 2008
UPLOAD Letter from the SEC Oct 7, 2008 —
UPLOAD Letter from the SEC Oct 7, 2008 —
10KSB/A Filing Oct 3, 2008 Dec 31, 2007
CORRESP Letter to the SEC Sep 25, 2008 —
10KSB/A Filing Sep 5, 2008 Dec 31, 2007
CORRESP Letter to the SEC Aug 20, 2008 —
NT 10-Q Filing Aug 13, 2008 Jun 30, 2008
UPLOAD Letter from the SEC Jul 22, 2008 —
NT 10-Q Filing May 16, 2008 Mar 31, 2008
10KSB Filing Apr 15, 2008 Dec 31, 2007
NT 10-K Filing Apr 1, 2008 Dec 31, 2007
10QSB Filing Nov 14, 2007 Sep 30, 2007
10QSB Filing Aug 17, 2007 Jun 30, 2007
NT 10-Q Filing Aug 15, 2007 Jun 30, 2007
10QSB Filing May 21, 2007 Mar 31, 2007
NT 10-Q Filing May 16, 2007 Mar 31, 2007
10KSB Filing Apr 17, 2007 Dec 31, 2006
NT 10-K Filing Apr 2, 2007 Dec 31, 2006
10QSB Filing Nov 14, 2006 Sep 30, 2006
10QSB Filing Aug 21, 2006 Jun 30, 2006
NT 10-Q Filing Aug 15, 2006 Jun 30, 2006
10QSB Filing May 22, 2006 Mar 31, 2006
NT 10-Q Filing May 16, 2006 Mar 31, 2006
10KSB Filing Apr 28, 2006 Dec 31, 2005
NT 10-K Filing Apr 3, 2006 Dec 31, 2005
10QSB Nutra pharma corporation - september 30, 2005 Nov 22, 2005 Sep 30, 2005
NT 10-Q Notification of late filing Nov 15, 2005 Sep 30, 2005
10QSB Nutra pharma corp.- june 30, 2005 Aug 23, 2005 Jun 30, 2005
NT 10-Q Nutra pharma corp.- june 30, 2005 Aug 15, 2005 Jun 30, 2005
10QSB Filing May 26, 2005 Mar 31, 2005
NT 10-Q Filing May 16, 2005 Mar 31, 2005
10KSB Filing May 2, 2005 Dec 31, 2004
NT 10-K Filing Mar 30, 2005 Dec 31, 2004
10QSB/A Filing Feb 11, 2005 Jun 30, 2004
10QSB/A Filing Feb 11, 2005 Mar 31, 2004
10QSB Filing Dec 21, 2004 Sep 30, 2004
NT 10-Q Filing Nov 15, 2004 Sep 30, 2004
10QSB Filing Aug 27, 2004 Jun 30, 2004
NT 10-Q Filing Aug 16, 2004 Jun 30, 2004
10QSB March 31, 2004 10q report May 26, 2004 Mar 31, 2004
NT 10-Q Notification of late filing May 17, 2004 Mar 31, 2004
10KSB/A December 31, 2003 10k amendment May 7, 2004 Dec 31, 2003
10KSB 2003 year end report Apr 20, 2004 Dec 31, 2003
NT 10-K 10k notification of late filing Mar 30, 2004 Dec 31, 2003
10QSB September 30, 2003 quarterly report Nov 19, 2003 Sep 30, 2003
NT 10-Q Notification of late filing for september 30, 2003 10q Nov 14, 2003 Sep 30, 2003
10QSB/A Corrected june 30, 2003 10q Oct 3, 2003 Jun 30, 2003
10QSB/A June 30, 2003 quarterly report - amendment Sep 24, 2003 Jun 30, 2003
10QSB June 2003 Aug 14, 2003 Jun 30, 2003
10QSB/A March 31, 2003 quarterly amended Jun 19, 2003 Mar 31, 2003
10KSB/A Amendment to add section 302 certifications only Apr 24, 2003 Dec 31, 2002
NT 10-K Notification of late filing 2002 10k Mar 28, 2003 Dec 31, 2002
NT 10-Q Notification of late filing Nov 13, 2002 Sep 30, 2002
10KSB 10k Apr 2, 2002 Dec 31, 2001
NT 10-K Extension form Apr 1, 2002 Dec 31, 2001
DEFS14A Definitive proxy statement Oct 25, 2001 Nov 3, 2001
SB-2/A Sb-2/a and prospectus Apr 6, 2001 —
SB-2/A Sb-2/a and prospectus Mar 28, 2001 —
SB-2/A Sb-2/a and prospectus Mar 14, 2001 —
SB-2/A Sb-2/a and prospectus Mar 1, 2001 —
8-A12G 8-a Dec 19, 2000 —
SB-2/A Sb-2/a and prospectus Nov 13, 2000 —
SB-2/A Sb-2/a and prospectus Oct 5, 2000 —
SB-2/A Sb-2/a and prospectus Oct 3, 2000 —
SB-2 Sb-2 and prospectus Aug 24, 2000 —

Showing 109 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
NPHC (OTC)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1119643
Former names
CYBER VITAMIN COM (until Feb 28, 2002)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.